Integrated Cardiac Safety: Assessment Methodologies for Noncardiac Drugs in Discovery, Development, and Postmarketing Surveillance

Integrated Cardiac Safety: Assessment Methodologies for Noncardiac Drugs in Discovery, Development, and Postmarketing Surveillance

Author(s): J. Rick Turner, Todd A. Durham

Published Online: 16 MAY 2008

Print ISBN: 9780470229644

Online ISBN: 9780470411292

DOI: 10.1002/9780470411292

About this Book

The serious nature of cardiovascular adverse drug reactions occurring in patients makes assessment of a drug's cardiac safety profile a high priority during both development and post-approval monitoring. Integrated Cardiac Safety provides necessary guidance and methodology for professionals assessing cardiac safety of drugs throughout all stages of the drug's life, from discovery and development through postmarketing research. This self-contained, reader-friendly text is valuable to professionals in the pharmaceutical, biotechnology, and CRO industries, pharmacologists, toxicologists, government officials, and students.

Table of contents

    1. You have free access to this content
  1. Part I: Introduction

  2. Part II: Cardiac Function and Pathology

  3. Part III: Drug Discovery and Nonclinical Development

  4. Part IV: Preapproval Clinical Development

  5. Part V: Postmarketing Assessment Methodologies

  6. Part VI: Behavioral Drug Safety

  7. Part VII: Integrative Discussion

    1. You have free access to this content
    1. You have free access to this content

SEARCH